James T. Borello
BBIO icon

James T. Borello’s BridgeBio Pharma BBIO Stock Holding History

James T. Borello’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$855 Sell
13
-1
-7% -$78 ﹤0.01% 1003
2026
Q2 		$1.04K Hold
14
– – ﹤0.01% 1015
2026
Q1 		$1.04K Buy
14
+4
+40% +$290 ﹤0.01% 1008
2025
Q4 		$765 Hold
10
– – ﹤0.01% 896
2025
Q3 		$519 Buy
+10
New +$488 ﹤0.01% 871

Other funds holding BBIO

Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Oak Ridge Investments
Oak Ridge Investments Chicago, Illinois $1.68B AUM 48.52% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Burney Company
Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

James T. Borello's BBIO Position: Q3 2026 in Review

James T. Borello reduced its BridgeBio Pharma (BBIO) stake by 7.1% in Q3 2026, selling an estimated $78 and leaving 13 shares worth $855. The position accounts for ﹤0.01% of the portfolio, ranked #1003.

James T. Borello first reported a position in BBIO in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.04K in Q2 2026. 106 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • James T. Borello held 13 shares of BridgeBio Pharma worth $855 as of Q3 2026.
  • James T. Borello sold 1 BridgeBio Pharma share in Q3 2026, an estimated $78.
  • BridgeBio Pharma made up ﹤0.01% of James T. Borello's portfolio in Q3 2026, its #1003 holding.
  • James T. Borello first reported a position in BridgeBio Pharma in Q3 2025 and has held it in 5 quarters since.
  • James T. Borello's BridgeBio Pharma position peaked at $1.04K in Q2 2026.
  • 106 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on James T. Borello's 13F filing for Q3 2026, filed 16 Oct 2026.